1.      Arad M, S.J., Seidman CE., Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet., 2002. 11(20): p. 2499-2506.

2.      Barth PG, S.H., Berden JA, et al. , An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci. , 1983. 62((1-3)): p. 327-355.

3.      Basso C, C.D., Marcus FI,et al., Arrhythmogenic right ventricular cardiomyopathy. Lancet, 2009. 373(9671): p. 1289-1300.

4.      Bonne G, D.B.M., Varnous S et al. , Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet., 1999. 21: p. 285-288.

5.      Bowles NE, N.J., Kearney DL et al., Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol., 2003. 42: p. 466-472.

6.      Burke MP, O.K., Fulminant heart failure due to selenium deficiency cardiomyopathy (Keshan disease). Med Sci Law., 2002. 42: p. 10-13.

7.      Connuck DM, S.L., Colan SD, et al., Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J., 2008. 155(6): p. 998-1005.

8.      Corrado D, B.C., Judge DP., Arrhythmogenic Cardiomyopathy. Circ Res., 2017. 121(7): p. 784-802.

9.      Denfield SW, W.S., Restrictive cardiomyopathy in childhood. . Heart Fail Clin., 2010. 6(4): p. 445-viii.

10.  Ditaranto R, C.A., Ferrara V, et al. , Pediatric Restrictive Cardiomyopathies. . Front Pediatr., 2022. 9: p. 745365.

11.  Elbl L, H.H., Tomaskova I et al., Long-term se- rial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients. Eur J Pediatr., 2005. 164: p. 678-684.

12.  Everitt MD, S.L., Lu M, et al., Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol., 2014. 63(14): p. 1405-1413.

13.  Farooki ZQ, H.W., Perry BL, Green EW., Myocardial dysfunction in hypothyroid children. . Am J Dis Child., 1983. 137: p. 65-68.

14.  Fatkin D, M.C., Sasaki T et al., Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomy- opathy and conduction-system disease. N Engl J Med., 1999. 341: p. 1715-1724.

15.  Feingold B, M.W., Auerbach S, et al., Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association. Circulation, 2017. 136(13): p. e200-e231.

16.  Fratz S, C.T., Greil GF, et al., Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. . J Cardiovasc Magn Reson., 2013. 15(1): p. 51.

17.  Friedman AH, F.M., Stephens P Jr, et al., Identification, imaging, functional as- sessment and management of congenital coronary arterial abnor- malities in children. Cardiol Young., 2007. 17(2): p. 56-67.

18.  Funakoshi M, T.Y., Arahata K. , Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy. . Neuromuscul Disord., 1999. 9(2): p. 108-114.

19.  Ho CY, C.P., Richard P, et al., Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res., 2015. 105(4): p. 397-408.

20.  Ho CY, D.S., Ashley EA, et al. , Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation, 2018. 138(14): p. 1387-1398.

21.  James CA, B.A., Tichnell C, et al. , Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. . J Am Coll Cardiol., 2013. 62(14): p. 1290-1297.

22.  Jefferies JL, W.J., Sleeper LA, et al., Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. . J Card Fail., 2015. 21(11): p. 877-884.

23.  Jenni R, O.E., Schneider J,et al., Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. . Heart., 2001. 86(6): p. 666-671.

24.  Kwok SY, C.F., Lo AF, et al., Variants of cardiomyopathy and hypertension in neuroblastoma. . J Pediatr Hematol Oncol., 2014. 36(3): p. e158-e161.

25.  Lorenzo M, L.A., Ashkanase J, et al., Symptomatic presentation influences outcomes in pediatric restrictive cardiomyopathy. . Front Pediatr., 2023. 11: p. 1264751.

26.  Lynch DR, R.S., Schadt KA et al., Management and therapy for cardiomyopathy in Friedreich's ataxia. Expert Rev Cardiovasc Ther. , 2012. 10(6): p. 767-777.

27.  Mahrholdt H, W.A., Deluigi CC et al., Presentation, patterns of myocardial damage, and clini- cal course of viral myocarditis. Circulation, 2006. 114: p. 1581-1590.

28.  Malinow I, F.D., Miyamoto M, et al., Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis. Front Pediatr. , 2024. 12: p. 1404942.

29.  Marcus FI, M.W., Sherrill D, et al. , Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. . Circulation, 2010. 121(13): p. 1533-1541.

30.  Maron BJ, D.M., Nishimura RA, et al., Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. . J Am Coll Cardiol., 2022. 79(4): p. 372-389.

31.  Maron BJ, G.J., Flack JM, et al., Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. . Circulation, 1995. 92(4): p. 785-789.

32.  Maron BJ, M.M., Hypertrophic cardiomyopathy. Lancet, 2013. 381(9862): p. 242-255.

33.  Maron BJ, R.E., Casey SA, et al. , Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. . J Am Coll Cardiol., 2015. 65(18): p. 1915-1928.

34.  Muchir A, B.G., van der Kooi AJ et al., Identification of mutations in the gene encod- ing lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet., 2000. 9: p. 1453-1459.

35.  Muchtar E, B.L., Gertz MA., Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res., 2017. 121(7): p. 819-837.

36.  Mulrooney DA, Y.M., Kawashima T et al., Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ, 2009. 339: p. b4606.

37.  Norwood F, d.V.M., Eymard B et al., EFNS Guideline Task Force. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol., 2007. 14(12): p. 1305-1312.

38.  Ocal B, U.S., Zorlu P, et al., Echocardiographic evaluation of cardiac functions and left ventricular mass in children with malnutrition. J Paediatr Child Health., 2001. 37: p. 14-17.

39.  Ommen SR, M.S., Burke MA, et al. , AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation., 2020. 142(25): p. e558-e631.

40.  Petersen SE, S.J., Wiesmann F, et al., Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol., 2005. 46(1): p. 101-105.

41.  Pignatelli RH, M.C., Dreyer WJ, et al. , Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. . Circulation, 2003. 108(21): p. 2672-2678.

42.  Rapezzi C, A.A., Barison A, et al., Restrictive cardiomyopathy: definition and diagnosis. Eur Heart J., 2022. 43(45): p. 4679-4693.

43.  Selcen D, O.K., Engel AG. , Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. . Brain, 2004. 127((Pt 2)): p. 439-451.

44.  Semsarian C, I.J., Maron MS, et al., New perspectives on the prevalence of hypertrophic cardiomyopathy. . J Am Coll Cardiol., 2015. 65(12): p. 1249-1254.

45.  Shimon I, A.S., Vered Z, et al., Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med., 1995. 98: p. 485-490.

46.  Towbin JA, L.A., Jefferies JL., Left ventricular non-compaction cardiomyopathy. . Lancet, 2015. 386(9995): p. 813-825.

47.  van Berlo JH, d.V.W., van der Kooi AJ et al., Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl). 2005. 83: p. 79-83.

48.  Zampieri M, D.F.C., Zocchi C, et al., Focus on Paediatric Restrictive Cardiomyopathy: Frequently Asked Questions. . Diagnostics (Basel), 2023. 13(24): p. 3666.